NCT00916123 Docetaxel/Prednisone Plus Fractionated 177Lu- J591 Antibody for Metastatic, Castrate-resistant Prostate Cancer Status COMPLETED Phase PHASE1
NCT00911859 A Study to Compare CNTO 328 (Anti-IL-6 Monoclonal Antibody) and VELCADE-Melphalan-Prednisone (VMP) With VMP Alone in Previously Untreated Multiple Myeloma Patients Status COMPLETED Phase PHASE2
NCT00911183 Diffuse Large B Cell Non-Hodgkin's Lymphoma in the Vulnerable/Frail Elderly. A Multicentric Randomized Phase II Trial Status COMPLETED Phase PHASE2
NCT00910754 A QT/QTc and Multi-Dose Pharmacokinetic Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer Status COMPLETED Phase PHASE1
NCT00900445 Studying Body Mass Index in Younger Patients Who Are Receiving Treatment for High-Risk Acute Lymphoblastic Leukemia Status WITHDRAWN Phase N/A
NCT00896519 GM-CSF, Rituximab, and Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Follicular Non-Hodgkin Lymphoma Status UNKNOWN Phase PHASE2
NCT00890617 Cryotherapy in Treating Patients With Primary Stage I Non-Small Cell Lung Cancer or Lung Metastasis Status COMPLETED Phase PHASE1
NCT00887198 Abiraterone Acetate in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer Status COMPLETED Phase PHASE3
NCT00882206 Pre-reinductive Decitabine and Vorinostat in Relapsed Lymphoblastic Lymphoma or Acute Lymphoblastic Leukemia Status TERMINATED Phase PHASE2
NCT00879619 Taxotere/Prednisone Plus Sunitinib in Chemotherapy-Naïve, Hormone Refractory Prostate Cancer Patients Status TERMINATED Phase PHASE1/PHASE2
NCT00877006 Study of Bendamustine Hydrochloride and Rituximab (BR) Compared With R-CVP or R-CHOP in the First-Line Treatment of Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL) - Referred to as the BRIGHT Study Status COMPLETED Phase PHASE3
NCT00873093 Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Status COMPLETED Phase PHASE2
NCT00866307 Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011) Status COMPLETED Phase PHASE1
NCT00842595 Efficacy , Safety of Treatment R NIMP for Relapsed Aggressive Lymphomas Status COMPLETED Phase PHASE2
NCT00841802 Chronic Rhinosinusitis With or Without Nasal Polyps Steroid Study Status WITHDRAWN Phase PHASE4